DGAP-Adhoc: Symrise AG: Mergers & Acquisitions: Signing of agreement to acquire International Dehydrated Foods, Inc., American Dehydrated Foods, Inc. as well as IsoNova Technologies LLC
|
DGAP-Ad-hoc: Symrise AG / Key word(s): Mergers & Acquisitions/Expansion
Symrise AG: Mergers & Acquisitions: Signing of agreement to acquire International Dehydrated Foods, Inc., American Dehydrated Foods, Inc. as well as IsoNova Technologies LLC
31-Jan-2019 / 21:29 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Symrise AG, Holzminden, ISIN: DE000SYM9999
Publication of an Inside Information according to Article 17 of Regulation (EU) Nr 596/2014
Mergers & Acquisitions: Signing of agreement to acquire International Dehydrated Foods, Inc., American Dehydrated Foods, Inc. as well as IsoNova Technologies LLC
Today, Symrise entered into an agreement to acquire all shares in International Dehydrated Foods LLC ("IDF"), American Dehydrated Foods LLC ("ADF") as well as IsoNova Technologies LLC ("IsoNova") of their respective shareholders as well as certain premises currently used by IDF, ADF and IsoNova from Darrco LLC. IDF, ADF and IsoNova are based in Missouri, USA.
IDF develops and produces pet food and food product solutions. The company is specialized in natural dehydrated meat and poultry ingredients. The company offers its products in fresh, frozen, concentrated, and powdered forms. It offers its products through a network of representatives in the United States and Canada; and serves customers in various countries worldwide, including Mexico, Central and South America, the Pacific Rim, Southeast Asia, China, Australia, New Zealand, and the Caribbean.
ADF develops, produces, and supplies ingredients to pet-food manufacturers. It offers chicken protein, chicken fat, and chicken broth ingredients for use in dog and cat foods, treats, and other consumable pet products. The company offers its products through distributors and representatives in the United States, Europe, Thailand, Taiwan, and the Philippines.
IsoNova produces pet food using egg protein specialties. It offers animal health, functional, and nutritional products.
The transaction is a strategic acquisition of an all-natural Nutrition business with annual sales of USD220 million and an adjusted EBITDA of USD51 million. The acquired companies do employ a total number of 470 employees. The transaction will be EPS accretive after closing.
Symrise plans to invest approximately USD 900 million for the acquisition in this transaction and has already secured the required bridge financing. Symrise plans to refinance such bridge financing - subject to market conditions - by a mix of debt and equity financing.
The transaction is subject to satisfaction of customary closing conditions.
Tobias Erfurth
Investor Relations
31-Jan-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
Symrise AG |
|
Mühlenfeldstraße 1 |
|
37603 Holzminden |
|
Germany |
| Phone: |
+49 (0)5531 90 0 |
| E-mail: |
[email protected] |
| Internet: |
www.symrise.com |
| ISIN: |
DE000SYM9999, DE000SYM7787, DE000SYM7704 |
| WKN: |
SYM999 |
| Indices: |
MDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| |
| End of Announcement |
DGAP News Service |
771447 31-Jan-2019 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
2.996,29 |
3.154,03 |
3.407,85 |
3.520,45 |
3.825,69 |
4.618,48 |
4.730,19 |
| EBITDA1,2 |
630,31 |
630,52 |
685,07 |
742,08 |
813,62 |
795,42 |
851,65 |
| EBITDA-Marge3 |
21,04 |
19,99 |
20,10 |
21,08 |
21,27 |
17,22 |
|
| EBIT1,4 |
431,59 |
433,97 |
455,35 |
487,51 |
558,96 |
503,98 |
559,36 |
| EBIT-Marge5 |
14,40 |
13,76 |
13,36 |
13,85 |
14,61 |
10,91 |
11,83 |
| Jahresüberschuss1 |
275,65 |
297,69 |
297,88 |
314,95 |
385,03 |
290,70 |
344,94 |
| Netto-Marge6 |
9,20 |
9,44 |
8,74 |
8,95 |
10,06 |
6,29 |
7,29 |
| Cashflow1,7 |
396,18 |
441,79 |
546,76 |
635,68 |
521,56 |
360,11 |
719,51 |
| Ergebnis je Aktie8 |
2,06 |
2,08 |
2,12 |
2,22 |
2,70 |
2,00 |
2,44 |
| Dividende8 |
0,88 |
0,90 |
0,95 |
0,97 |
1,02 |
1,10 |
0,85 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Ernst & Young
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Symrise |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| SYM999 |
104,100 |
Halten |
14.550,27 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 30,62 |
38,40 |
0,80 |
46,49 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 4,18 |
20,22 |
3,08 |
20,22 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 1,10 |
1,10 |
1,06 |
15.05.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 25.04.2024 |
01.08.2024 |
24.10.2024 |
06.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 1,43% |
6,58% |
4,48% |
-3,52% |
|
|
Symrise AG DE000SYM9999